ReviewMECHANOMEDICINE Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials View ORCID ProfileMarsha C. Lampi1 and View ORCID ProfileCynthia A. Reinhart-King2,*1Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14850, USA.2Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212, USA.↵*Corresponding author. Email: cynthia.reinhart-king{at}vanderbilt.edu See allHide authors and affiliations Science Translational Medicine 03 Jan 2018:Vol. 10, Issue 422, eaao0475DOI: 10.1126/scitranslmed.aao0475 Marsha C. Lampi 1Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14850, USA.Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Marsha C. Lampi Cynthia A. Reinhart-King 2Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212, USA.Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Cynthia A. Reinhart-King For correspondence: cynthia.reinhart-king@vanderbilt.edu Article Figures & Data Info & Metrics eLetters PDF Article Information vol. 10 no. 422 DOI: https://doi.org/10.1126/scitranslmed.aao0475 PubMed: 29298864 Published By: American Association for the Advancement of Science Print ISSN: 1946-6234 Online ISSN: 1946-6242 History: Received for publication June 12, 2017Accepted for publication December 8, 2017 . Copyright & Usage: Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works http://www.sciencemag.org/about/science-licenses-journal-article-reuseThis is an article distributed under the terms of the Science Journals Default License. Author Information Marsha C. Lampi1 and Cynthia A. Reinhart-King2,*1Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14850, USA.2Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212, USA.↵*Corresponding author. Email: cynthia.reinhart-king{at}vanderbilt.edu Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: December 2017 to January 2021 AbstractFullPdf Dec 2017121 Jan 201857985121046 Feb 201851792174 Mar 201849989140 Apr 201842068117 May 201845579111 Jun 20183665577 Jul 20182707668 Aug 2018441179101 Sep 201829015480 Oct 2018386229141 Nov 2018311170113 Dec 201831614581 Jan 2019332561457 Feb 2019427468345 Mar 2019438408287 Apr 2019437569350 May 2019356586287 Jun 2019202462211 Jul 2019159360194 Aug 2019153370162 Sep 2019152364149 Oct 2019102354181 Nov 201996337182 Dec 2019104204111 Jan 2020159350176 Feb 2020139433210 Mar 2020118331205 Apr 2020130346250 May 202078424216 Jun 202064363228 Jul 202059285183 Aug 202046256105 Sep 202068249149 Oct 202040322148 Nov 202057291205 Dec 202060312184 Jan 202127216112 View Full Text
Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials By Marsha C. Lampi, Cynthia A. Reinhart-King Science Translational Medicine03 Jan 2018 Targeting extracellular matrix stiffness holds clinical potential to attenuate pathological progression in the emerging field of mechanomedicine.
Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials By Marsha C. Lampi, Cynthia A. Reinhart-King Science Translational Medicine03 Jan 2018 Targeting extracellular matrix stiffness holds clinical potential to attenuate pathological progression in the emerging field of mechanomedicine.